A detailed history of Allworth Financial LP transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Allworth Financial LP holds 228 shares of ORGO stock, worth $1,212. This represents 0.0% of its overall portfolio holdings.

Number of Shares
228
Holding current value
$1,212
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 30, 2025

BUY
$2.89 - $6.21 $658 - $1,415
228 New
228 $0
Q4 2022

Jan 13, 2023

BUY
$2.48 - $3.43 $416 - $576
168 New
168 $0

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $696M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.